Search research articles
Contact Us
Filters
Showing results (91-100 of 139) with videos related to
Page
of 14
Sort By:
The Journal of Urology
|
July 1, 1986
Clinical results of allopurinol treatment in prevention of calcium oxalate stone formation
H G Tiselius, L Larsson, E Hellgren
European Urology
|
January 1, 1984
Diurnal variation of urine composition in calcium oxalate stone disease during treatment with bendroflumethiazide
C Ahlstrand, H G Tiselius, L Larsson
Urological Research
|
January 1, 1980
Urine composition in patients with urolithiasis during treatment with magnesium oxide
H G Tiselius, C Ahlstrand, L Larsson
Annals of Clinical Biochemistry
|
January 1, 1992
Clinical significance of phosphate in calcium oxalate renal stones
S Ohman, L Larsson, H G Tiselius
International Journal of Technology Assessment in Health Care
|
December 11, 1986
Impact of extracorporeal lithotripsy on patient management. Intermediate results from the Swedish assessment study
P Carlsson, B Jösson, H G Tiselius
Urological Research
|
January 1, 1996
Risk factors of calcium stone formation in patients with primary Sjögren's syndrome
P Eriksson, T Denneberg, H G Tiselius
European Urology
|
January 1, 1988
Hemiacidrin: a useful component in the treatment of infectious renal stones
I Wall, H G Tiselius, L Larsson
Urological Research
|
January 1, 1990
Effects of different doses of alkaline citrate on urine composition and crystallization of calcium oxalate
C Berg, L Larsson, H G Tiselius
Acta Chirurgica Scandinavica
|
January 1, 1983
Effects of calcium, aluminium, magnesium and cholestyramine on hyperoxaluria in patients with jejunoileal bypass
B Nordenvall, L Backman, L Larsson, et al.
Urological Research
|
January 1, 1993
The effects of citrate and urine on calcium oxalate crystal aggregation
H G Tiselius, A M Fornander, M A Nilsson
Page
of 14
Search research articles
Search
Showing results (91-100 of 139) with videos related to
Sort By:
Page
of 14
The Journal of Urology
|
July 1, 1986
Clinical results of allopurinol treatment in prevention of calcium oxalate stone formation
H G Tiselius, L Larsson, E Hellgren
European Urology
|
January 1, 1984
Diurnal variation of urine composition in calcium oxalate stone disease during treatment with bendroflumethiazide
C Ahlstrand, H G Tiselius, L Larsson
Urological Research
|
January 1, 1980
Urine composition in patients with urolithiasis during treatment with magnesium oxide
H G Tiselius, C Ahlstrand, L Larsson
Annals of Clinical Biochemistry
|
January 1, 1992
Clinical significance of phosphate in calcium oxalate renal stones
S Ohman, L Larsson, H G Tiselius
International Journal of Technology Assessment in Health Care
|
December 11, 1986
Impact of extracorporeal lithotripsy on patient management. Intermediate results from the Swedish assessment study
P Carlsson, B Jösson, H G Tiselius
Urological Research
|
January 1, 1996
Risk factors of calcium stone formation in patients with primary Sjögren's syndrome
P Eriksson, T Denneberg, H G Tiselius
European Urology
|
January 1, 1988
Hemiacidrin: a useful component in the treatment of infectious renal stones
I Wall, H G Tiselius, L Larsson
Urological Research
|
January 1, 1990
Effects of different doses of alkaline citrate on urine composition and crystallization of calcium oxalate
C Berg, L Larsson, H G Tiselius
Acta Chirurgica Scandinavica
|
January 1, 1983
Effects of calcium, aluminium, magnesium and cholestyramine on hyperoxaluria in patients with jejunoileal bypass
B Nordenvall, L Backman, L Larsson, et al.
Urological Research
|
January 1, 1993
The effects of citrate and urine on calcium oxalate crystal aggregation
H G Tiselius, A M Fornander, M A Nilsson
Page
of 14